Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ASND
HALO
Add up to 3 more stocks
ASND
Ascendis Pharma A/S
-0.87%
$226.05-1.98Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$14.04B
52W Range
$186.05 - $282.15
HALO
Halozyme Therapeutics, Inc.
+1.30%
$109.72+1.41Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$13.01B
52W Range
$61.23 - $116.85
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 17.18 | 32.75 |
| Forward P/E | N/A | 13.04 |
| PEG Ratio | N/A | 1.43 |
| P/B Ratio | 8.56 | 90.66 |
| P/S Ratio | 11.49 | 7.82 |
| P/FCF Ratio | 36.30 | 16.14 |
| EV/EBITDA | 92.96 | 14.22 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 90.2% | 78.2% |
| Operating Margin | -18.9% | 56.8% |
| Net Margin | 71.1% | 24.9% |
| ROE | 53.0% | 288.1% |
| ROA | 33.3% | 16.1% |
| ROIC | 5.8% | 27.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.99 | 2.71 |
| Quick Ratio | 2.32 | 2.31 |
| Debt/Equity | 0.31 | 14.95 |
| Interest Coverage | -1.69 | 45.03 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.